Event

Building a High Quality US-Mexico Pharmaceutical Supply Chain

Binational Seminar to promote conversations and interactions between US and Mexico participants on partnering to strengthen the US-Mexico Pharmaceutical Supply Chain.

Date & Time

Tuesday

Oct. 17, 2023

1:30pm – 5:05pm ET

Location

5th Floor, Woodrow Wilson Center
and Online

Event Sponsors

Mexico Institute

Wahba Institute for Strategic Competition

Agenda

Objectives

Describe the current framework that could allow interactions between US and Mexican players to partner on pharmaceutical nearshoring efforts to build up a strong binational quality supply chain for APIs and medicines.
Show commitment, policies, and initiatives of US and Mexican governments to strengthen the US-Mexico pharmaceutical quality supply chain through nearshoring initiatives.
Show the capabilities of the innovative and generic pharmaceutical industries to provide quality APIs and medicines to strengthen the US-Mexico supply chain.

Organization

Co-organizers: United States Pharmacopeia, The Wilson Center, Mexico Institute, and the US Embassy in Mexico.
Sponsorship: Mexican Association of Pharmaceutical Laboratories (AMELAF)

Tuesday, October 17

01:30pm – 01:45pm ET

Policy Challenges to Create a US-Mexico Quality Pharmaceutical Supply Chain

Andrew I. Rudman, Director, Mexico Institute, Wilson Center
Jerry Haar, Florida International University

01:45pm – 03:00pm ET

Regulatory Framework, Initiatives, and Policies to support US-Mexico trade in pharmaceuticals and ingredients

Maria Julia Marinissen, Health Attache, US Embassy and Acting Director, US Section - Border Health Commission, Department of Health and Human Services *

Kevin Webb, Chief Operating Officer, API Innovation Center

Leigh Verbois, Director, Office of Drug Security, Integrity and Response, FDA

Vimala Raghavendran, Vice President, Informatics Product Development, USP

Moderator: Anthony Lakavage, Senior Vice President, Global External Affairs, USP

* indicates the panelist is participating virtually

03:00pm – 03:15pm ET

Keynote Address, Remote

Raquel Buenrostro, Secretary of Economy

03:15pm – 03:25pm ET

Keynote Address, Remote

Alejandro Svarch, Federal Commissioner of the Federal Commission for Protection Against Sanitary Risks (COFEPRIS)

03:25pm – 03:40pm ET

Networking Break

**In person participants only**

03:40pm – 04:55pm ET

US-Mexico Binational Pharmaceutical Industry

Juan de Villafranca, Executive President, Mexican Association of Pharmaceutical Laboratories (AMELAF)

Cristobal Thompson, Executive Director, Mexican Association of Pharmaceutical Innovation Industries (AMIIF) *

Javier Aceves, Director, PiSA Farmaceutica

Constanza Lozada, CEO, Pfizer Mexico *

Moderator: Eduardo Gonzalez Pier, Global Fellow, Mexico Institute, Wilson Center

* indicates the panelist is participating virtually

04:55pm – 05:05pm ET

Closing Remarks

Andrew I. Rudman, Director, Mexico Institute, Wilson Center

Anthony Lakavage, Senior Vice President, Global External Affairs, USP

05:05pm – 06:15pm ET

Cocktail Reception

4th Floor Atrium

**In person participants only**

Introductions

Andrew I. Rudman

Public Policy Fellow

Jerry Haar

Global Fellow;
Professor of International Business and Executive Director for the Americas, College of Business, Florida International University

Keynote Speakers

Moderators

Eduardo González Pier

Global Fellow;
Global Fellow, Wilson Center; Senior Technical Director; Palladium

Anthony Lakavage

Senior Vice President, Global External Affairs, United States Pharmacopeia

Panelists

Maria Julia Marinissen

Health Attache, Embassy of the United States in Mexico

Vimala Raghavendran

Vice President, Informatics Product Development, United States Pharmacopeial

Juan de Villafranca

Executive President, Mexican Association of Pharmaceutical Laboratories (AMELAF)

Kevin Webb

Chief Operating Officer of the API Innovation Center

Cristobal Thompson

Executive Director of the Mexican Association of Pharmaceutical Research Industries

Javier Aceves

Director, PiSA Farmaceutica

Constanza Lozada

CEO, Pfizer Mexico

Leigh Verbois

Director, Office of Drug Security, Integrity and Response, Federal Drug Administration

Hosted By

Mexico Institute

The Mexico Institute seeks to improve understanding, communication, and cooperation between Mexico and the United States by promoting original research, encouraging public discussion, and proposing policy options for enhancing the bilateral relationship. A binational Advisory Board, chaired by Luis Téllez and Earl Anthony Wayne, oversees the work of the Mexico Institute. Read more

Wahba Institute for Strategic Competition

The Wahba Institute for Strategic Competition works to shape conversations and inspire meaningful action to strengthen technology, trade, infrastructure, and energy as part of American economic and global leadership that benefits the nation and the world. Read more

Thank you for your interest in this event. Please send any feedback or questions to our Events staff.